pla-695
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2006 (NCT00366262)
Timeline
Indications
Mechanism of action
- Cytosolic phospholipase A2INHIBITOR
PLA2G4A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pla-695
- pla-695
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00440492 | Phase 1 | Dec 1, 2006 | Pfizer, Wyeth |
| NCT00396955 | Phase 2 | Nov 1, 2006 | Pfizer, Wyeth |
| NCT00366262 | Phase 1 | Jun 1, 2006 | Pfizer, Wyeth |
Showing 3 of 3 trials
Page 1 / 1